Project Walk Atlanta: Spinal Cord Injury Stimulation Treatment Philip Lavin, PhD, FASA, FRAPS Wolfgang Schaden MD for Tissue Regeneration Technologies.

Slides:



Advertisements
Similar presentations
BTEC Level 5 Sport & Remedial Massage Therapy LSSM 25 A Weekend 3 Types of Injury.
Advertisements

Consultant Orthopedic & Spinal Surgeon
Sleep, Pain, and Fatigue in Ehlers-Danlos Syndrome Ehlers-Danlos National Foundation Learning Conference August 9, 2012 Susan Cordes, MS, CGC.
This Outcome report is based on data from clients who completed a Pain Management Programme at the RealHealth Treatment Centre in Coventry between May.
Clinical Case Studies Developed by Dr. David Hunt.
MSK Case Presentation David Stone May 22, yo Lacrosse Player ~2 weeks ago, he was hit in his quadricep with a lacrosse stick. –Initial injury.
Long-term Safety and Effectiveness of Natalizumab STRATA MS Study.
1 Efficacy of Testosterone Transdermal System (TTS) for Treatment of HSDD in Surgically Menopausal Women on Concomitant Estrogen Daniel Davis, MD, MPH.
Spinal Trauma. Anatomy and Physiology  Vertebral Column  Spinal Cord.
Injuries to the Shoulder Region
Short-term outcomes after endovascular treatment for chronic cerebrospinal venous insufficiency (CCSVI) in patients with multiple sclerosis Kenneth Mandato,
Local Application of heat and cold to the body can be therapeutic, but before using these therapies, the nurse must understand normal body responses to.
A Case of Acute Spinal Trauma Scott Silvers, MD, FACEP.
InFUSE ™ Bone Graft / LT-CAGE ™ Lumbar Tapered Fusion Device IDE Clinical Results G Hallett H. Mathews, M.D. Richmond, Virginia.
The Basics of Healing - Understanding the Inflammation Process.
SPINAL TUMORS. GROUP MEMBERS:  Carlwyn Collins  Jennifer Haynes  Satrupa Devi Singh  Vanessa Wickham.
CAUTION: The Spinal Modulation Axium™ Spinal Cord Stimulator System is an investigational device and is limited by United States law to investigational.
Recreational Therapy: An Introduction Chapter 11: Physical Medicine and Rehabilitation Practice PowerPoint Slides.
Ranjith Babu, MS 1 Jonathan Choi, MD 1 Adam Back, MD 1 Vijay Agarwal, MD 1 Matthew Hazzard, MD 1 Beatrice Ugiliweneza, MSPH PhD 2 Chirag G. Patil, MD MS.
Hamstring Strain PE 709 Advanced Care and Prevention Of Athletic Injuries Diane Stankevitz.
Spinal Cord Injuries.  There are an estimated 10,000 to 12,000 spinal cord injuries every year in the United States.  The cost of managing the care.
A Case of Acute Spinal Trauma Andy Jagoda, MD, FACEP.
What is the spinal cord? The spinal cord is a bundle of nerve fibers and associated tissue that is enclosed in the spine. These fibers connect nearly.
 Head and neck cancer is the 6 th leading cancer world wide.  Oral Mucositis is one of the most frequent complications seen in the treatment of head.
General Injuries. Soft-Tissue Injuries  Aka wounds  When a tissue is injured, it may bleed, become inflamed or produce extra fluid  Handout of Soft.
Basics of Tissue Injury Chapter 2. Soft Tissue Injury AKA wounds When the tissue is injured it may bleed, become inflamed or produce extra fluid.
Orthopedic Assessment Jan Bazner-Chandler CPNP, CNS, MSN, RN.
Effect of hydrotherapy in the rehabilitative treatment of Multiple Sclerosis (MS) Volanti P, Scialabba G, De Cicco D. Neurorehabilitation Unit Fondazione.
Ardiana Murtezani MD, PhD 1, 2, Nerimane Abazi MD 1,2, Zana Ibraimi PHARM PhD 2,Fatime Haxholli MD 1,2, Zana Agani DDS PhD 2,3, Elena Kamberi DDS 2.
{ Spinal Cord Injury A complete or Incomplete break in the Spinal Cord.
Acute Spinal Cord Trauma Robert L Wears, MD, MS Practice Guidelines: A Pan-American Symposium Santiago de Chile 7 October 2003.
1 Classification of Injuries. Sign: a finding that is observed or that can be objectively measured (swelling, discoloration, deformity, crepitus) Sign.
Center for Injury Research and Policy Perceived Need and Unmet Need for Support Services Following Severe Lower Extremity Trauma.
Guillain-Barre’ Syndrome
1 ENTEREG ® (Alvimopan) Special Safety Section Marjorie Dannis, M.D. Division of Gastroenterology Products Office of Drug Evaluation III CDER, FDA The.
4 Evaluation and Assessment. The means by which one seeks information on severity, irritability, nature, and stage of injury Evaluation Subjective elements.
Efficacy and Tolerability of the Diclofenac Epolamine Patch in the Treatment of Minor Soft Tissue Injury W Carr, P Beks, C Jones, S Rovati, M Magelli,
Musculoskeletal Injuries. Definition Any injury that occurs to a skeletal muscle, tendon, ligament, joint, or a blood vessel that services skeletal muscle.
Chapter 28 and 29 Post Surgical Rehabilitation. Overview Although many musculoskeletal conditions can be treated conservatively, surgical intervention.
You can assess pain Module 4. Learning objectives ■ Describe how to carry out a pain assessment ■ Take a holistic history and make a problem list ■ Discuss.
CE-1 IRESSA ® Clinical Efficacy Ronald B. Natale, MD Director Cedars Sinai Comprehensive Cancer Center Ronald B. Natale, MD Director Cedars Sinai Comprehensive.
CV-1 Trial 709 The ISEL Study (IRESSA ® Survival Evaluation in Lung Cancer) Summary of Data as of December 16, 2004 Kevin Carroll, MSc Summary of Data.
: Intermittent Neurogenic Claudication Aperius ® Percutaneous Interspinous Spacer F. Collignon, P. Fransen, D Morelli, N. Craig, J. Van Meirhaeghe For.
Efficacy of Topical Azithromycin & Cyclosporine A(CsA) vs CsA Alone in the Treatment of Dry Eyes Associated with Blepharitis Kenneth A. Beckman, M.D.,
Local Application of heat and cold to the body can be therapeutic, but before using these therapies, the nurse must understand normal body responses to.
Soft Tissue Injuries By: Kerri Populo Period 8. What is a Soft Tissue Injury? Damage of the soft tissue of the body.
mild Decompression for the Treatment of Lumbar Spinal Stenosis
 Spinal cord carries nerve impulses from brain to body & back  Single injury can affect many organs & body functions.
Safety, Efficacy and Duration of Effect of RT002, a Botulinum Toxin Type A for Injection, to Treat Glabellar Lines: The Phase 2 BELMONT Study Authors:
Spinal Cord Injury Gail Lupica PhD, RN, CNE Nurs 211.
Multiple Sclerosis. Multiple sclerosis (MS) is a disease that affects central nervous system (brain and spinal cord). It damages the myelin sheath. 
WHAT IS HAND THERAPY? WHAT IS HAND THERAPY? Treating more than just a hand… Hand Therapy Week [Insert dates]
HYPERBARIC OXYGEN FOR TREATMENT OF STROKE AND TRAUMATIC BRAIN INJURIES ABSTRACT TITLE : HYPERBARIC OXYGEN FOR TREATING STROKE AND TRAUMATIC BRAIN INJURY.
IN THE NAME OF GOD FARAJI.Z.MD.
KCHC Neuropathology Jianying Zeng, MD Chandrakant Rao, MD
Neal B, et al. Diabetes Care 2015;38:403–411
Stem Cell Therapy In Scottsdale Read More:
Hip, Thigh & Pelvis Injuries
Unexpected Recovery After Robotic Locomotor Training at Physiologic Stepping Speed: A Single-Case Design  Martina R. Spiess, PT, MPTSc, Jeffrey P. Jaramillo,
Unexpected Recovery After Robotic Locomotor Training at Physiologic Stepping Speed: A Single-Case Design  Martina R. Spiess, PT, MPTSc, Jeffrey P. Jaramillo,
Post-Acute Rehabilitation Length of Stay and Traumatic Brain Injury Outcome Jessica Ashley, Ph.D. 42nd Traumatic Brain Injury Rehabilitation Conference.
Krop I et al. SABCS 2009;Abstract 5090.
Box and Whisker Plots 50% Step 1 – Order the series.
N3-378 Template 12/31/2018 7:52 PM 8 8.
Spinal Column Fall 2018.
Classifying incomplete spinal cord injury syndromes: Algorithms based on the International Standards for Neurological and Functional Classification of.
Hallett H. Mathews, M.D. Richmond, Virginia
Injury and Recovery.
Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease  James J. Schuler,
Presentation transcript:

Project Walk Atlanta: Spinal Cord Injury Stimulation Treatment Philip Lavin, PhD, FASA, FRAPS Wolfgang Schaden MD for Tissue Regeneration Technologies LLC 1

Patient (n=10) Characteristics Gender: 6M, 4F Age range: years TSI range: months Injury Sites: – C3, C5, C6(2), C7, T3(3), T4, T10 Laminectomy: 9N, 1Y ASIA Score: 6A, 4B Para/Quad: 6P, 4Q Injury: – 6 Complete, 4 Incomplete Injury type: – 5 moving vehicles – 2 gunshots – 1 diving – 1 post-surgical – 1 pedestrian Lesion type: – 3 bruised – 3 squeezed/crushed – 2 ruptured – 1 compression fracture – 1 unknown 2

Treatment History TRT stimulation completed: 10/10 Time treated range: – 7-39 wks (median 12.5 wks) # TRT treatments: – 5-17 (median 10) Total shocks (x1000): – (median 42.45) Highest energy (mJ/m 2 ): – (median 0.14) All study therapy completed as planned Other therapies: 4/10 – 1 hyperbaric and IMT – 1 hyperbaric – 1 rehabilitation – 1 stem cells Physical therapy: – 4-40 hrs (median 29 hrs) 3

Project Walk Metric Improvement Significant mean improvements (two-sided p=0.004, sign test) relative to baseline #BaselineExitChangeTSI (m), LesionInjury SiteInjury Type , RupturedC5Q, Complete , BruisedT3P, Complete ThermalT3P, Incomplete 413NA 93, BruisedT10P, Complete , CrushedC3Q, Incomplete , Comp FxC6Q, Incomplete , RupturedC6Q, Complete , SqueezedT3P, Incomplete , BruisedC7P, Complete , CrushedT4P, Complete 4

Efficacy Scoring NA: Not applicable -2: Much worse relative to baseline -1: Worse relative to baseline 0: Same as baseline +1: Better than baseline +2: Much better than baseline +3: Returned to normal 5

Efficacy Measures Spasticity Core Strength Core Movement Core Sensitivity Leg Muscle Mass Leg Extremity Strength Leg Extremity Movement Leg Extremity Sensitivity Leg Extremity Reflexes Bladder Function Bowel Function Sexual Function Lung and Diaphram Perspiration below injury Sensitivity to cold Nerve pain Wounds (not included) – Scar appearance – Chronic ulcers 6

Case Specific Best Improvements Multi-dimensional improvements for all cases #Best 1 st Best 2 nd Best 3 rd TSI (m), LesionInjury Type 1Lung/Diaph +36 of 15 others +283, RuptureQ, Complete 2Core Str +2Core Mov +23 others +227, BruisedP, Complete 3Leg Ex Se +28 of 14 others MissingP, Incomplete 4Spasticity +2Leg Ex Mv +2Leg Ex R +293, BruisedP, Complete 58 of 15 measures +1112, CrushedQ, Incomplete 6Core Mov +26 of 14 others +138, Comp FxQ, Incomplete 78 of 15 measures +127, RuptureQ, Complete 86 of 14 measures +166, SqueezedP, Incomplete 92 of 16 measures +133, BruisedP, Complete 10Lung/Diaph +3Core S/M +2All 5 Leg +214, CrushedP, Complete 7

Degree of Improvement (1) Efficacy Measure Spasticity (2 rated -1)0133 Core Strength0352 Core Movement0433 Core Sensitivity0082 Leg Muscle Mass0226 Leg Extremity Strength0253 Leg Extremity Movement0343 Leg Extremity Sensitivity0244 Leg Extremity Reflexes0253 8

Degree of Improvement (2) Efficacy Measure Bladder Function0019 Bowel Function00010 Sexual Function0109 Lung and Diaphram (4 NA)2022 Perspiration below injury0343 Sensitivity to cold0154 Nerve Pain (1 rated -1)0016 9

Best Overall Improvement (3) Efficacy Measure Spasticity (2 rated -1)0133 Best Core Measure0460 Best Leg Measure0460 Best Function Measure0118 Lung and Diaphram (4 NA)2022 Perspiration below injury0343 Best Sensory Measure0352 Best Overall

Mean # Measures Improving Per Case Multidimensional benefits as shown below: Measure Score Total Cases With At Least One Such Score Total # Measures With That Score Overall Average Per 10 Cases

Overall Efficacy Results Confidence All patients experienced improvements Lower 95% confidence bounds beyond chance Best OutcomePercent Achieving95% Lower Bound +320%5.1% +2 or +360%33.6% +1 or +2 or +3100%74.1% 12

Patient Self Assessment (1-10) 1 = baseline with 10 = total recovery Favorable self-perception of improvement RatingPercent Achieving95% Lower Bound At least 2100%74.1% At least 390%65.0% At least 460%33.6% At least 550%25.1% At least 620%5.1% At least 710%1.0% 13

Correlations Correlation Coefficient

Correlations Correlation Coefficient

Correlations Correlation Coefficient

Correlations Correlation Patient/Therapist Survey: % Improvement DAS Evaluation: % Improvement from baseline to Normal Project Walk Baseline DAS Score Improvement % Patient Self Assessment: % Improvement to normal Correl. to hrs. of Therapy Correl. to # of treatments Correl. to # of shock Correl. to wks. in study Number of treatments, & more importantly, weeks since 1 st treatment are most significant factors for measurable improvements.

DATA 18 MINMAXMedianMean Number of weeks in Study Number of Treatments Total # of Shocks Highest energy (mj/mm ^2) Hours of Therapy during study Final Project Walk evaluation Median & Mean were similar for data sets Most patients received low energy shocks

What We Can Take from the Data # of treatments, # of shocks, & weeks in study: Positive correlation for assessments While relatively similar numbers of each for each patient, the small differences were key Time since first treatment was most important Positive correlation of at least 0.47 for weeks in study, with independent evaluation =

Wound Assessments Wound healing was also observed for all wounds Chronic ulcers healed for all 3 patients with chronic ulcers at baseline Scar appearance improved for all 7 patients with scars; the other 3 patients did not have scars – much better (+2) for 2 patients – improved (+1) for 5 patients 20

Safety 1 case (#3) had small bruises on their foot which was classified as mild and resolved No cases had any distal adverse events 21

Moving Forward All experienced improvement from baseline – Mean number of improvements: 0.2 resolved, 2.4 much better, and 5.2 improved => 7.8 per case Multi-dimensional treatment benefit – 20% +3, 60% +2, and 100% +1 relative to baseline 4 of 6 completes and 2 of 4 incompletes experienced +2 or +3 – Project Walk metric confirmation – Patient self assessment confirmation No safety issues All willing to continue treatment 22

The End 23

DATA MINMAXMedianMean Patient/Therapist: % Improvement4%42%20%22% Independent: % Improvement5%23%10%11% Project Walk Improvement %13%250%31%65% Patient Self Assessment20%70%45%43% 24 The Median & Mean were equivalent for virtually all forms of assessment While treatments were relatively similar for each patient, all saw an improvement!